It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
作者信息
Kay Alexander W, Ness Tara E, Martinez Leonardo, Mandalakas Anna M
机构信息
1Baylor College of Medicine Children's Foundation Eswatini, Mbabane, Eswatini.
2Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
出版信息
Am J Trop Med Hyg. 2020 Oct;103(4):1348-1349. doi: 10.4269/ajtmh.20-1089.
Abstract
摘要
相似文献
1
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.未到终局，焉能言败：新冠病毒、结核病和艾滋病的三重威胁
Am J Trop Med Hyg. 2020 Oct;103(4):1348-1349. doi: 10.4269/ajtmh.20-1089.
2
Race to find COVID-19 treatments accelerates.寻找新冠病毒治疗方法的竞赛加速。
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
3
Audio Interview: New Data on Remdesivir in Covid-19.音频访谈：瑞德西韦治疗新冠病毒病的新数据
N Engl J Med. 2020 May 28;382(22):e94. doi: 10.1056/NEJMe2019975.
4
Case Report: COVID-19 Recovery from Triple Infection with , HIV, and SARS-CoV-2.病例报告：COVID-19 患者合并感染 、HIV 和 SARS-CoV-2 后康复。
Am J Trop Med Hyg. 2020 Oct;103(4):1597-1599. doi: 10.4269/ajtmh.20-0756.
5
Uncertainty about the Efficacy of Remdesivir on COVID-19.瑞德西韦对COVID-19疗效的不确定性。
J Korean Med Sci. 2020 Jun 15;35(23):e221. doi: 10.3346/jkms.2020.35.e221.
6
Missed Opportunities on Emergency Remdesivir Use.瑞德西韦紧急使用中的错失机会
JAMA. 2020 Jul 28;324(4):331-332. doi: 10.1001/jama.2020.11932.
7
COVID-19: Rescue by transcriptional inhibition.新型冠状病毒肺炎：通过转录抑制进行挽救。
Sci Adv. 2020 Jul 1;6(27). doi: 10.1126/sciadv.abc6891. Print 2020 Jul.
8
Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective.瑞德西韦及其与精神药物的潜在相互作用：从COVID-19角度看
Prim Care Companion CNS Disord. 2020 May 28;22(3):20com02664. doi: 10.4088/PCC.20com02664.
9
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.针对 SARS-CoV-2 感染的候选化学药物和中药的抗病毒机制。
Virus Res. 2020 Sep;286:198073. doi: 10.1016/j.virusres.2020.198073. Epub 2020 Jun 24.
10
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.瑞德西韦的紧急使用授权：透明分配流程的必要性。
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
引用本文的文献
1
Biochemical characterization of RNA polymerases.RNA 聚合酶的生化特性分析。
J Bacteriol. 2024 Oct 24;206(10):e0025624. doi: 10.1128/jb.00256-24. Epub 2024 Sep 24.
2
Restoring non-COVID-19 clinical research and surveillance in Oyo state, Nigeria during the SARS-CoV-2pandemic.在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行期间恢复尼日利亚奥约州的非2019冠状病毒病临床研究和监测。
J Public Health Afr. 2022 Oct 26;13(3):1720. doi: 10.4081/jphia.2022.1720. eCollection 2022 Sep 7.
3
A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and .大流行中的其他大流行。当宿主发生多重感染时：严重急性呼吸综合征冠状病毒2、人类免疫缺陷病毒和……
Viruses. 2021 May 17;13(5):931. doi: 10.3390/v13050931.
本文引用的文献
1
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria.2019冠状病毒病对结核病治疗的影响：尼日利亚一家治疗中心的经验
Int J Tuberc Lung Dis. 2020 Sep 1;24(9):981-982. doi: 10.5588/ijtld.20.0418.
2
How COVID-19 could benefit tuberculosis and HIV services in South Africa.新冠疫情如何能让南非的结核病和艾滋病服务受益。
Lancet Respir Med. 2020 Sep;8(9):844-846. doi: 10.1016/S2213-2600(20)30311-8. Epub 2020 Aug 3.
3
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study.COVID-19 大流行对中低收入国家中艾滋病毒、结核病和疟疾的潜在影响：建模研究。
Lancet Glob Health. 2020 Sep;8(9):e1132-e1141. doi: 10.1016/S2214-109X(20)30288-6. Epub 2020 Jul 13.
4
Effect of COVID-19 on Tuberculosis Notification, South Korea.韩国 COVID-19 对结核病报告的影响。
Emerg Infect Dis. 2020 Oct;26(10):2506-2508. doi: 10.3201/eid2610.202782. Epub 2020 Jul 16.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.描述感染 HIV 的个体中的 COVID-19：单中心前瞻性队列研究。
Lancet HIV. 2020 Aug;7(8):e554-e564. doi: 10.1016/S2352-3018(20)30164-8. Epub 2020 May 28.
7
Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019.2019年冠状病毒病住院的人类免疫缺陷病毒感染者的临床特征及预后
Clin Infect Dis. 2020 Nov 19;71(16):2294-2297. doi: 10.1093/cid/ciaa635.
8
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.结核病、COVID-19 和移民：对两个队列中 69 例死亡患者的初步分析。
Pulmonology. 2020 Jul-Aug;26(4):233-240. doi: 10.1016/j.pulmoe.2020.05.002. Epub 2020 May 14.
9
Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.感染新型冠状病毒肺炎的人类免疫缺陷病毒患者的临床特征与预后
Clin Infect Dis. 2020 Nov 19;71(16):2276-2278. doi: 10.1093/cid/ciaa579.
10
Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?为什么感染艾滋病毒的人患重症2019冠状病毒病（COVID-19）的风险没有更高？
AIDS Patient Care STDS. 2020 Jun;34(6):247-248. doi: 10.1089/apc.2020.29005.com. Epub 2020 May 14.
Zotero 插件